Zenas.
Person
- Reports this week
- 0
- Active events
- 1
- Connections
- 15
What's happening
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Zenas this week
News at the entities that move Zenas most-
FDA TransactionalGeneric medicine services are seeking approval for launch from the FDA.Moves Zenas
-
Royalty Pharma TransactionalVisteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.Moves Zenas
-
United Therapeutics OperationalUnited Therapeutics filed Form 13F with the Securities and Exchange Commission.Moves Zenas
-
Relay Therapeutics OperationalAnalyst reports compare market performance factors between Relay Therapeutics and I-Mab.Moves Zenas
-
Arcturus Therapeutics OperationalArcturus Therapeutics' products are being used in Europe as a patient market for OTC deficiency.Moves Zenas
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Zenas
Connections
The 9 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Royalty Pharma Transactional
Royalty Pharma provided funding to Zenas in exchange for a royalty on sales.
-
Nasdaq Structural
Zenas operates as a listed entity on the Nasdaq stock exchange.
-
FDA Transactional
The FDA formally accepted Zenas's Biologics License Application, granting it market access.
-
United Therapeutics Operational
The evidence suggests both entities are healthcare companies actively competing for market share.
-
Relay Therapeutics Operational
The evidence suggests both entities operate in the mid-cap healthcare sector and are in competition.
-
LinkedIn Mentioned together
Zenas utilizes LinkedIn as a platform to access company and investor relations information.
-
Waltham Shared context
Zenas operates from a headquarters situated in Waltham, Massachusetts.
-
Arcturus Therapeutics Operational
Both entities are healthcare companies actively competing for investment opportunities.
Show all 9 connections
-
Bristol-Myers Squibb Mentioned together
No evidence was provided in the timeline to establish a relationship between Bristol-Myers Squibb and Zenas.